Rapid HBV DNA decrease (week 12) is an important prognostic factor for first-line treatment with adefovir dipivoxil for chronic hepatitis B
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-08-01
著者
-
Bock Thomas
Department Of Molecular Pathology University Of Tuebingen
-
Kaiser Stephan
Center For Liver And Infectious Diseases
-
HASS Holger
Department of Internal Medicine and Oncology, Paracelsus Hospital
-
NEHLS Oliver
Department of Gastroenterology, Hepatology and Oncology, Hospital Bad Canstatt
-
Hass Holger
Department Of Internal Medicine And Oncology Paracelsus Hospital
-
Nehls Oliver
Department Of Gastroenterology Hepatology And Oncology Hospital Bad Canstatt